New patent granted assists hospitals with greater coverage to support drug diversion prevention
Protenus, provider of the leading healthcare compliance analytics platform, today announced a new grant of a U.S. Patent that supports its ongoing efforts to deliver drug diversion surveillance technology that enables hospitals and health systems to be more efficient and proactively eliminate risk to their organization and patients.
The new grant of U.S. Patent No. 11,923,062 is titled “Methods and Systems for Analyzing Accessing of Drug Dispensing Systems.” With this patent, Protenus now holds six granted U.S. patents covering various techniques for detecting anomalous drug dispensing events. For example, the newly-granted patent covers numerous techniques such as using pattern-based algorithms to identify hidden drug misappropriation events as part of an AI-driven approach.
“Our research estimates that one in 100 healthcare employees are diverting narcotics away from patient care,” states Nick Culbertson, CEO and Co-Founder of Protenus. Read more >
This post is related to:
Software: Drug Diversion Monitoring, Diversion Prevention
